CBIHOTCServices-Commercial Physical & Biological ResearchFiscal year ends May 31

Cannabis Bioscience International Holdings, Inc.

Financials through Q3 FY2026, quarter ended Feb 28, 2026Last filing: 10-Q on Apr 16, 2026

$0.00+0.00 (+33.33%)

Close on Oct 19, 2026

Market cap: $2.33M
P/E (TTM): –
Dividend yield: –

Cannabis Bioscience International Holdings, Inc. income statement

Millions of USD, except per-share data. Shares in millions.

Line item	FY 2025 2025-05-31	FY 2024 2024-05-31	FY 2023 2023-05-31
Revenue	0.30	0.25	0.32
Cost of Revenue	0.04	0.05	0.09
Gross Profit	0.26	0.20	0.22
General & Administrative	0.10	0.12	0.18
Operating Expenses	0.68	0.69	1.21
Operating Income	-0.42	-0.49	-0.98
Interest Expense	0.14	0.15	0.09
Other Non-Operating Income	-0.13	-0.17	-0.05
Income Tax Expense	–	0	0
Net Income	-0.55	-0.65	-1.03
EPS (Basic)(per share)	-0.0001	-0.0001	-0.0001
EPS (Diluted)(per share)	-0.0001	-0.0001	-0.0001
Shares Outstanding (Basic, Weighted)(shares)	10,716	10,318	9,002
Shares Outstanding (Diluted, Weighted)(shares)	10,716	10,318	9,002

Italic numbers are calculated by StockData (for example Q4 = full year − nine months). Per-share data and share counts are adjusted for stock splits. Hover a number for its source; click it to open the filing on SEC.gov. Click a row to chart it.

Ratios

Latest available, balances at Feb 28, 2026

Profitability, TTM

Gross margin: 78.8%
Operating margin: -322.6%
Net margin: -416.8%
Return on equity, FY2025: 48.9%

Financial strength

Current ratio: 0.00
Debt to equity: -0.18
Debt to assets: 17104.4%
Cash to current liabilities: 0.0%

Valuation

P/E ratio: –
Price to sales: 18.81
Price to book: –
Dividend yield: –